Prognostic value of the progesterone receptor by subtype in patients with estrogen receptor‐positive, HER‐2 negative breast cancer
K Van Asten, L Slembrouck, S Olbrecht… - The …, 2019 - academic.oup.com
Background In estrogen receptor‐positive (ER+), human epidermal growth factor receptor 2
(HER‐2) negative breast cancers, the progesterone receptor (PR) is an independent …
(HER‐2) negative breast cancers, the progesterone receptor (PR) is an independent …
[HTML][HTML] Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor‐Positive, HER‐2 Negative Breast Cancer
K Van Asten, L Slembrouck, S Olbrecht, L Jongen… - The …, 2019 - ncbi.nlm.nih.gov
Background. In estrogen receptor-positive (ER+), human epidermal growth factor receptor 2
(HER-2) negative breast cancers, the progesterone receptor (PR) is an independent …
(HER-2) negative breast cancers, the progesterone receptor (PR) is an independent …
Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer.
K Van Asten, L Slembrouck, S Olbrecht, L Jongen… - The oncologist, 2019 - folia.unifr.ch
RESULTS In total, 4,228 patients from Leuven and 5,419 from BIG 1-98 were analyzed. In
the Leuven cohort, the adjusted hazard ratio (HR) of PR-positive versus PR-negative tumors …
the Leuven cohort, the adjusted hazard ratio (HR) of PR-positive versus PR-negative tumors …
[PDF][PDF] Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor‐Positive, HER‐2 Negative Breast Cancer
K Van Asten, L Slembrouck, S Olbrecht… - The …, 2019 - Wiley Online Library
Background In estrogen receptor‐positive (ER+), human epidermal growth factor receptor 2
(HER‐2) negative breast cancers, the progesterone receptor (PR) is an independent …
(HER‐2) negative breast cancers, the progesterone receptor (PR) is an independent …
Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer.
K Van Asten, L Slembrouck, S Olbrecht, L Jongen… - The …, 2018 - europepmc.org
Background In estrogen receptor-positive (ER+), human epidermal growth factor receptor 2
(HER-2) negative breast cancers, the progesterone receptor (PR) is an independent …
(HER-2) negative breast cancers, the progesterone receptor (PR) is an independent …
Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor‐Positive, HER‐2 Negative Breast Cancer.
K Van Asten, L Slembrouck, S Olbrecht… - …, 2019 - search.ebscohost.com
Background. In estrogen receptor-positive (ER+), human epidermal growth factor receptor 2
(HER-2) negative breast cancers, the progesterone receptor (PR) is an independent …
(HER-2) negative breast cancers, the progesterone receptor (PR) is an independent …
Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer
K Van Asten, L Slembrouck, S Olbrecht, L Jongen… - THE …, 2019 - air.unimi.it
Background: In estrogen receptor-positive (ER+), human epidermal growth factor receptor 2
(HER-2) negative breast cancers, the progesterone receptor (PR) is an independent …
(HER-2) negative breast cancers, the progesterone receptor (PR) is an independent …
Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer.
K Van Asten, L Slembrouck, S Olbrecht, L Jongen… - The oncologist, 2019 - sonar.ch
RESULTS In total, 4,228 patients from Leuven and 5,419 from BIG 1-98 were analyzed. In
the Leuven cohort, the adjusted hazard ratio (HR) of PR-positive versus PR-negative tumors …
the Leuven cohort, the adjusted hazard ratio (HR) of PR-positive versus PR-negative tumors …
[PDF][PDF] Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer
K VAN ASTEN, L SLEMBROUCK, S OLBRECHT… - 2018 - academia.edu
Background. In estrogen receptor-positive (ER+), human epidermal growth factor receptor 2
(HER-2) negative breast cancers, the progesterone receptor (PR) is an independent …
(HER-2) negative breast cancers, the progesterone receptor (PR) is an independent …
Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer
K Van Asten, L Slembrouck, S Olbrecht… - The …, 2019 - pubmed.ncbi.nlm.nih.gov
Background In estrogen receptor-positive (ER+), human epidermal growth factor receptor 2
(HER-2) negative breast cancers, the progesterone receptor (PR) is an independent …
(HER-2) negative breast cancers, the progesterone receptor (PR) is an independent …